Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury
Article first published online: 6 DEC 2005
Copyright © 1990 American Association for the Study of Liver Diseases
Volume 12, Issue 6, pages 1295–1299, December 1990
How to Cite
Parés, A., Barrera, J. M., Caballería, J., Ercilla, G., Bruguera, M., Caballería, L., Castillo, R. and Rodés, J. (1990), Hepatitis C virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology, 12: 1295–1299. doi: 10.1002/hep.1840120608
- Issue published online: 6 DEC 2005
- Article first published online: 6 DEC 2005
- Manuscript Accepted: 13 JUN 1990
- Manuscript Received: 3 NOV 1989
- Comisión Asesora de Investigación Científica y Técnica. Grant Number: PA85 0078
- Ministerio de Educación y Ciencia
- Fundació Catalana per a l'Estudi de les Malalties del Fetge
The prevalence of hepatitis C virus antibody and its relationship to the severity of liver disease in chronic alcoholic patients has been assessed, using a recently developed enzyme immunoassay and confirmed by a recombinant immunoblot assay, in 144 patients (mean age ± S.D. = 44.4 ± 11.3 yr) who had consumed >80 gm/day ethanol for >5 yr. Hepatic disease was evaluated by clinical and biochemical studies and by liver biopsy when appropriate. In addition, 76 liver biopsy specimens from these patients were analyzed to determine whether liver lesions were similar in alcoholic patients with and without hepatitis C virus antibodies.
According to clinical and histological features alcoholic patients were divided into five groups: normal liver (45 patients), fibrosteatosis (20 patients), alcoholic hepatitis (14 patients), cirrhosis (61 patients) and chronic hepatitis (4 patients). Hepatitis C virus antibodies were present in 35 alcoholic patients (24.3%). The prevalence of hepatitis C virus antibodies correlated with the severity of liver injury: 2.2% in patients without liver disease, 20% in those with fibrosteatosis, 21.4% in those with alcoholic hepatitis and 42.6% in those with cirrhosis. Hepatitis C virus antibodies were found in one of the four patients with chronic hepatitis (p < 0.001). Furthermore, patients positive for hepatitis C virus antibodies with normal liver or fibrosteatosis showed higher serum bilirubin and γ-globulin concentrations and lower aminopyrine breath test scores than did patients negative for hepatitis C virus antibodies with normal liver or fibrosteatosis. Similar differences between patients with and without hepatitis C virus antibodies were observed in patients with alcoholic hepatitis or cirrhosis. Histological features, except cells within sinusoids, were comparable in alcoholic patients with and without hepatitis C virus antibodies.
The increased prevalence of hepatitis C virus antibodies in alcoholic patients with severe liver injury and the impaired liver function in patients with these antibodies suggest that hepatitis C virus is involved in liver damage in chronic alcoholic patients (HEPATOLOGY 1990;12:1295–1299).